戻る
Abivax SA (ABVX)価格
ABVX 株価推移チャート
ABVX 収入
Abivax SA
$117.1
0.25%
$0.29
終値： Jan 16, 16:00:00 GMT-5
$116.93
-0.14%
$-0.16
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$116.8
始値
$116.79
当日レンジ
$116.02 - $119.24
52週レンジ
$4.77 - $148.83
取引高
777.2K
平均取引高
1.6M
1株当たり利益(TTM)
-3.62
配当利回り
--
時価総額
$9.1B
ABVXとは何ですか？
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 69 full-time employees. The company went IPO on 2015-06-26. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The firm's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.